MedPath

Prevalence and predicting factors of significant liver fibrosis in chronic hepatitis B aged 40 years or more

Completed
Conditions
Prevalence and predicting factors of significant liver fibrosis evaluated by transient elastography in patients with chronic hepatitis B aged 40 years or more.
Chronic hepatitis B, liver fibrosis, aged 40 years or more, prevalence, predicting factors
Registration Number
TCTR20220126005
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

1. Patients with chronic hepatitis B with age 40 years or more
2. No evidence of decompensated cirrhosis
3. Transient elastography is performed before anti-viral drugs intimidation or within 1 months after initiation
4. Transient elastography is performed by qualified physicians and its result is qualified.

Exclusion Criteria

1. No evidence of hepatocellular carcinoma or cholangiocarcinoma
2. ALT > 5 times of upper limit normal
3. Conditions affecting liver stiffness results e.g. heart failure, ascites, ESRD, cholestasis
4. Pregnancy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevalence At time performing transient elastography Number of significant fibrosis patients/Number of overall patients
Secondary Outcome Measures
NameTimeMethod
Predicting factors of significant liver fibrosis At the end of study Multi variable logistic regression analysis
© Copyright 2025. All Rights Reserved by MedPath